Evidence map›Paper›PMID 40143764›Full record

ArticleAdvanced healthcare materials2025

Enhancing Form Stability: Shrink-Resistant Hydrogels Made of Interpenetrating Networks of Recombinant Spider Silk and Collagen-I.

Xuen J Ng, Tilman U Esser, Vanessa T Trossmann, Christoph Rudisch, Maren Fiedler, Kaveh Roshanbinfar, Zan Lamberger, Philipp Stahlhut, Gregor Lang, Thomas Scheibel and 1 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  2. Review
  3. Article
  4. Nanostructured Protein Surfaces Inspired by Spider Silk.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xuen J NgChair of Biomaterials, University of Bayreuth, Prof.-Rüdiger-Bormann-Str. 1, 95447, Bayreuth, Germany.
Tilman U EsserExperimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology and Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, 91054, Erlangen, Germany.
Vanessa T TrossmannChair of Biomaterials, University of Bayreuth, Prof.-Rüdiger-Bormann-Str. 1, 95447, Bayreuth, Germany.
Christoph RudischChair of Biomaterials, University of Bayreuth, Prof.-Rüdiger-Bormann-Str. 1, 95447, Bayreuth, Germany.
Maren FiedlerExperimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology and Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, 91054, Erlangen, Germany.
Kaveh RoshanbinfarExperimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology and Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, 91054, Erlangen, Germany.
Zan LambergerDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, D-97070, Würzburg, Germany.
Philipp StahlhutDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, D-97070, Würzburg, Germany.
Gregor LangDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, D-97070, Würzburg, Germany.
Thomas ScheibelChair of Biomaterials, University of Bayreuth, Prof.-Rüdiger-Bormann-Str. 1, 95447, Bayreuth, Germany.
Felix B EngelExperimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology and Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, 91054, Erlangen, Germany.ORCID 0000-0003-2605-3429

Funding

Deutsche Forschungsgemeinschaft 326998133 - TRR 225Deutsche Forschungsgemeinschaft INST 410/91-1 FUGGResearch Foundation Medicine at the University Clinic Erlangen, GermanyUniversitätsklinikum Erlangen ELAN IZKFUniversitätsklinikum Erlangen P093/ Aktenzeichen: 21-05-20-1-Roshanbinfar
6 · The paper itself

Abstract

Tissue engineering enables the production of tissues and organ-like structures as models for drug testing and mechanistical studies or functional replacements for injured tissues. Available cytocompatible materials are limited in number, suffer from insufficient mechanical properties, and cells interacting with them often cause construct shrinkage. As shape is important for function, identifying cytocompatible, shrink-resistant materials are a major aim. Here, it is shown that hydrogels made of interpenetrating networks of collagen-I and recombinant spider silk protein eADF4(C16)-RGD nanofibrils exhibit synergistic and tunable mechanical properties. Composite hydrogels allow cell adhesion and spreading and are resistant to shrinkage mediated by fibroblasts, C2C12 myoblasts, and human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Myoblasts differentiate and fuse into myotubes, and hiPSC-cardiomyocytes can be cultured long-term, show spontaneous contractions, and remain drug responsive. Collectively, a novel composite material is developed to overcome the challenge of post-fabrication matrix shrinkage conferring high shape fidelity suitable for tissue engineering.

Indexed as

Collagen Type IHydrogelsSilkAnimalsCell AdhesionCell LineHumansInduced Pluripotent Stem CellsMiceMyoblastsMyocytes, CardiacNanofibersRecombinant ProteinsSpidersTissue EngineeringCollagen Type IHydrogelsRecombinant ProteinsSilkbiopolymercardiac tissue engineeringcompactionheartshrinkage

Identifiers

PMID40143764
PMCPMC12057611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.